Biotech · Private company
Xalud Therapeutics, Inc.
Track this companyFree. Adds Xalud Therapeutics, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials41 recruiting or active
Pipeline programs3From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline3
- XT-150Phase 2 · Facet Joint PainClinicalTrials.gov · fetched Nov 12, 2026
- XT-150Phase 2 · Osteoarthritis, KneeClinicalTrials.gov · fetched Nov 12, 2026
- XT-150Phase 1 · Amyotrophic Lateral Sclerosis (ALS)ClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials4
- Safety Study of XT-150 in Participants With ALSPHASE1 · NOT_YET_RECRUITING · started Mar 1, 2027ClinicalTrials.gov NCT06704347 · fetched Nov 12, 2026
- Safety and Efficacy of XT-150 for Facet Joint Osteoarthritis PainPHASE2 · COMPLETED · started Feb 24, 2022ClinicalTrials.gov NCT05196919 · fetched Nov 12, 2026
- Efficacy and Safety of XT-150 in Osteoarthritis of the KneePHASE2 · COMPLETED · started Feb 14, 2020ClinicalTrials.gov NCT04124042 · fetched Nov 12, 2026
- Safety, Tolerability, and Efficacy of XT-150 for the Treatment of Osteoarthritic PainPHASE1 · COMPLETED · started Jun 8, 2018ClinicalTrials.gov NCT03477487 · fetched Nov 12, 2026